- Henry Schein press release ( NASDAQ: HSIC ): Q2 Non-GAAP EPS of $1.11 misses by $0.05 .
- Revenue of $3B (+1.4% Y/Y) misses by $120M .
- Affirms guidance for full-year 2022 GAAP diluted EPS attributable to Henry Schein, Inc. of $4.75 to $4.91, reflecting growth of 7% to 10% compared with 2021 GAAP diluted EPS of $4.45 and growth of 5% to 9% compared with 2021 non-GAAP diluted EPS of $4.52.
- Updates full-year 2022 expected sales growth to be approximately 3% to 6% over 2021. This compares with previous guidance for growth of 5% to 8% over 2021 and reflects adverse effects from foreign exchange rates and a decrease in anticipated sales of PPE and COVID-related products, including COVID-19 test kits. Sales of COVID-19 test kits are now expected to decline 25% to 30% from 2021, versus a previously estimated decline of 15% to 25%.
For further details see:
Henry Schein Non-GAAP EPS of $1.11 misses by $0.05, revenue of $3B misses by $120M